Bredt David

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bredt David's trades of Rapport Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
11.19
Quantity 34,000
Value US$380,460
Transaction date
Proposed sale
Price
10.02
Quantity 25,500
Value US$255,510
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-19 2026-02-17
PlS Planned sale
55,404 +44.1%
368.15
US$1,146,482 		55,404 +44.1% 368.15 US$1,146,482
2026-02-19 2026-02-17
PlS Planned sale
25,980 +42.3%
118.78
US$4,326,883 		25,980 +42.3% 118.78 US$4,326,883
2026-02-19 2026-02-17
PlS Planned sale
44,345 +3.6%
14.97
US$637,330 		44,345 +3.6% 14.97 US$637,330
2026-01-16 2026-01-15
PlS Planned sale
200 -0.1%
27.40
US$5,480 		200 -0.1% 27.40 US$5,480
2026-01-16 2026-01-15
PlS Planned sale
8,300 -2.1%
26.83
US$222,652 		8,300 -2.1% 26.83 US$222,652
2026-01-15 2026-01-15
PrS Proposed sale
17,000
27.42
US$466,140 		17,000 27.42 US$466,140
2026-01-02 2026-01-02
PrS Proposed sale
6,567
30.05
US$197,338 		6,567 30.05 US$197,338
2026-01-05 2025-12-31
S Sale
6,567 -1.6%
30.05
US$197,338 		6,567 -1.6% 30.05 US$197,338
2025-12-16 2025-12-15
PlS Planned sale
796 -0.2%
30.68
US$24,419 		796 -0.2% 30.68 US$24,419
2025-12-16 2025-12-15
PlS Planned sale
7,704 -1.9%
29.95
US$230,711 		7,704 -1.9% 29.95 US$230,711
2025-11-18 2025-11-17
PlS Planned sale
5,344 -1.3%
25.39
US$135,696 		5,344 -1.3% 25.39 US$135,696
2025-11-18 2025-11-17
PlS Planned sale
3,156 -0.8%
24.84
US$78,395 		3,156 -0.8% 24.84 US$78,395
2025-10-16 2025-10-15
PlS Planned sale
1,082 -0.3%
26.16
US$28,310 		1,082 -0.3% 26.16 US$28,310
2025-10-16 2025-10-15
PlS Planned sale
7,418 -1.8%
25.73
US$190,887 		7,418 -1.8% 25.73 US$190,887
2025-10-15 2025-10-15
PrS Proposed sale
25,500
24.88
US$634,440 		25,500 24.88 US$634,440
2025-09-17 2025-09-15
PlS Planned sale
3,402 -0.8%
24.66
US$83,888 		3,402 -0.8% 24.66 US$83,888
2025-09-17 2025-09-15
PlS Planned sale
5,098 -1.2%
23.88
US$121,761 		5,098 -1.2% 23.88 US$121,761
2025-08-18 2025-08-15
PlS Planned sale
200 -0.0%
15.79
US$3,158 		200 -0.0% 15.79 US$3,158
2025-08-18 2025-08-15
PlS Planned sale
8,300 -1.9%
14.98
US$124,308 		8,300 -1.9% 14.98 US$124,308
2025-07-16 2025-07-15
PlS Planned sale
8,500 -1.9%
14.00
US$118,962 		8,500 -1.9% 14.00 US$118,962
2025-06-18 2025-06-16
PlS Planned sale
8,500 -1.9%
11.00
US$93,522 		8,500 -1.9% 11.00 US$93,522
2025-06-16 2025-06-16
PrS Proposed sale
34,000
11.19
US$380,460 		34,000 11.19 US$380,460
2025-05-19 2025-05-15
PlS Planned sale
8,500 -1.8%
9.56
US$81,262 		8,500 -1.8% 9.56 US$81,262
2025-04-16 2025-04-15
PlS Planned sale
8,500 -1.8%
9.57
US$81,310 		8,500 -1.8% 9.57 US$81,310
2025-03-17 2025-03-14
PlS Planned sale
8,500 -1.8%
10.85
US$92,205 		8,500 -1.8% 10.85 US$92,205
2025-03-14 2025-03-14
PrS Proposed sale
25,500
10.02
US$255,510 		25,500 10.02 US$255,510